Chemokine expression in experimental tubulointerstitial nephritis

Area of Science:

• Nephrology
• Immunology
• Molecular Biology

Background:

• Tubulointerstitial nephritis is a key feature of glomerular disease.
• Chemokines mediate leukocyte infiltration in inflammatory kidney diseases.

Purpose of the Study:

• To investigate the role of specific chemokines in puromycin aminonucleoside (PAN) nephrosis-induced tubulointerstitial nephritis.
• To determine the cellular source and temporal expression of chemokines during PAN nephrosis.

Main Methods:

• Quantitative analysis of renal cortical chemokine mRNA expression (IP-10, MCP-1, RANTES, CINC, MIP-2, MIP-1alpha) at various time points post-PAN induction.
• Localization of chemokine mRNA production using in situ hybridization.
• Measurement of MCP-1 protein levels via ELISA.
• Assessment of tubulointerstitial leukocyte infiltration (T lymphocytes, macrophages).
• In vivo blockade of MCP-1 using a neutralizing antibody.

Main Results:

• A significant, transient increase in renal cortical IP-10 and MCP-1 mRNA expression was observed 6-8 days after PAN administration.
• IP-10 and MCP-1 mRNA were produced by intrinsic tubulointerstitial cells.
• MCP-1 protein levels correlated with increased T lymphocyte and macrophage infiltration, peaking around day 10.
• Neutralization of MCP-1 led to a 45% reduction in tubulointerstitial macrophage infiltration on day 6.

Conclusions:

• MCP-1 is a critical chemokine involved in monocyte/macrophage recruitment in PAN nephrosis.
• IP-10 may also play a role in the inflammatory process.
• Targeting MCP-1 could be a therapeutic strategy for tubulointerstitial nephritis associated with glomerular disease.